Agilent Technologies, Inc. $A Shares Purchased by Envestnet Asset Management Inc.

Key Points

• Envestnet Asset Management increased its Agilent Technologies stake by 36.2% in the second quarter, adding 250,989 shares for a total holding of 943,900 shares worth approximately $125.4 million.
• Agilent reported quarterly earnings of $1.62 per share, beating estimates of $1.49, while revenue rose 8.1% year over year to $1.88 billion. The company issued fiscal 2026 EPS guidance of $6.18–$6.21.
• Analysts maintain a generally positive outlook, with the stock receiving a “Moderate Buy” consensus rating and an average price target of $170.33. Agilent also declared a quarterly dividend of $0.255 per share, representing a 0.6% yield.

Envestnet Asset Management Inc. raised its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 36.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 943,900 shares of the medical research company's stock after buying an additional 250,989 shares during the period. Envestnet Asset Management Inc. owned 0.33% of Agilent Technologies worth $125,378,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of A. State Street Corp increased its stake in shares of Agilent Technologies by 0.7% during the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company's stock worth $1,710,658,000 after purchasing an additional 89,598 shares during the last quarter. Geode Capital Management LLC raised its stake in Agilent Technologies by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company's stock valued at $1,006,519,000 after buying an additional 25,139 shares during the period. Wellington Management Group LLP raised its stake in Agilent Technologies by 2.7% in the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company's stock valued at $990,206,000 after buying an additional 198,253 shares during the period. Deutsche Bank AG lifted its position in shares of Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company's stock valued at $930,957,000 after buying an additional 1,024,516 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of Agilent Technologies by 87.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company's stock worth $695,227,000 after acquiring an additional 2,440,360 shares during the period.

Agilent Technologies Trading Down 0.1%

NYSE A opened at $172.60 on Friday. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The business has a fifty day simple moving average of $149.16 and a 200 day simple moving average of $131.40. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $174.77. The firm has a market capitalization of $48.66 billion, a P/E ratio of 33.98, a PEG ratio of 2.63 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same period in the prior year, the company earned $1.37 earnings per share. Agilent Technologies's revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be paid a dividend of $0.2550 per share. The ex-dividend date of this dividend is Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. Agilent Technologies's dividend payout ratio (DPR) is currently 20.08%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on A. Stifel Nicolaus raised their target price on shares of Agilent Technologies from $170.00 to $180.00 and gave the stock a "buy" rating in a research note on Thursday, August 27th. TD Cowen raised their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock a "buy" rating in a research report on Thursday, August 27th. Piper Sandler began coverage on Agilent Technologies in a report on Thursday, June 11th. They set a "neutral" rating and a $150.00 price objective for the company. Weiss Ratings raised Agilent Technologies from a "hold (c)" rating to a "hold (c+)" rating in a research report on Friday, September 11th. Finally, Sanford C. Bernstein increased their target price on Agilent Technologies from $155.00 to $180.00 and gave the stock an "outperform" rating in a research note on Thursday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $170.33.

Insider Transactions at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the company's stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the transaction, the director owned 4,924 shares in the company, valued at approximately $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company's offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.